A U.S.-based registry of adults with neuromyelitis optica spectrum disorder (NMOSD) shows that most patients are receiving biologic therapies, either approved or not approved for NMOSD, in real-world care, according to a study of its first 350 participants. The registry, called SPHERES, has enrolled about half of…
Discussion
Why does it seem like every Google search I do regarding my health blames my weakened immune system for whatever is happening on a particular day? Take, for example, one simple question I innocently asked: “Why are my feet so dry?” Suddenly, I was knee-deep in results suggesting I was…
People with neuromyelitis optica spectrum disorder (NMOSD) who are negative for typical disease-driving antibodies show several differences in clinical features compared with antibody-positive NMOSD patients, but responses to conventional treatments seem largely comparable, according to a new study. “Our findings support the utility of conventional [immune-suppressing treatments] in this…
NMOSD is a progressive autoimmune disease where the immune system mistakenly attacks nerve cells, affecting the nervous system. Learn more about the disease here.
Scientists do not know the exact underlying cause of NMOSD. Self-reactive antibodies that target AQP4 are known to play a major role. Learn more about what causes the disease here.
When the disease affects the optic nerve (optic neuritis), it can result in pain inside the eye and possibly blurry vision or vision loss. Learn more about the symptoms of the disease here.
Get regular updates to your inbox.
